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Sodium channels are thought to be macromolecular 
complexes composed of tens of different proteins (Abriel 
et al. 2015). The pore-forming protein is known as the α 
subunit, and is sufficient to generate sodium currents. All 
α subunits include a voltage sensor that promotes chan-
nel opening when the cell membrane is depolarized by a 
few millivolts. Sodium channels thus activate, generate 
the sodium currents that underlie the initial depolarisation 
phase of the action potential, and then inactivate within 
tens of milliseconds, critically shaping cell repolarisation 
(Zilberter et al. 1994).
There are nine isoforms of the voltage-gated sodium 
channel α subunit, and each form has distinct expression 
and electrophysiological patterns. In this review, we have 
considered the main sodium channel isoforms expressed in 
the central neuronal system (CNS), i.e., SCN1A (NaV1.1), 
SCN2A (NaV1.2), SCN3A (NaV1.3) and SCN8A (NaV1.6). 
Wherever relevant we have also included additional infor-
mation regarding other isoforms, including SCN5A (gen-
erally known as the cardiac isoform, NaV1.5) and SCN9A 
(mainly expressed in the peripheral nervous system, 
NaV1.7), (Dib-Hajj et al. 2013).
Sodium channel α subunits are large (ca. 2000 residues), 
hydrophobic, integral membrane proteins that have been 
fascinating (and challenging) a range of scientific com-
munities including biochemists, pharmacists, neuroscien-
tists, and electrophysiologists for more than three decades 
(Catterall 2015). Although detailed mammalian voltage-
gated sodium channel structures are not yet available, it is 
widely accepted that the topology of α subunits at the pro-
tein level consists of four homologous domains (termed DI 
to DIV), each consisting of six transmembrane helices, and 
joined by cytosolic interdomain linkers (Yu and Catterall 
2003). The N and C termini of α subunits are also intra-
cellular. Thus, cytosolic interdomain linkers, and N- and 
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Introduction
Voltage-gated sodium channels are essential proteins 
in brain physiology. Upon voltage-mediated activation, 
sodium channels produce sodium currents responsible for 
depolarisation of excitable cells, including neurons and 
cardiomyocytes. From the point of view of biomedical sci-
ences and pathophysiology, brain disorders such as some 
forms of epilepsy have long been directly associated with 
voltage-gated sodium channel malfunction.
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C-terminal domains of α subunits are accessible to intracel-
lular enzymes that catalyse post-translational modifications 
(PTM) of the channels.
In this review, we aim to integrate progress in our under-
standing of CNS voltage-gated sodium channel regula-
tion at the transcriptional and post-translational level. The 
reader will find that much more is known on sodium chan-
nel PTMs than on the transcriptional mechanisms that reg-
ulate channel expression. Consequently, the weight of the 
review is balanced towards PTMs. Our focus is strongly 
centred on recent research lines, and newly generated 
knowledge. The goal is to facilitate dissemination of recent 
developments with a view on fostering further relevant 
research.
Regulation of brain sodium channel expression 
at the transcriptional level
In this section, we have considered the regulation of CNS 
voltage-gated sodium channels by transcription factors, and 
by alternative splicing. The regulation of sodium channels 
at the post-transcriptional level (e.g., by microRNAs) is out 
of the scope of the present review.
Regulation by transcription factors
Promoter regions of brain voltage-gated sodium chan-
nel genes have been described, including SCN1A (Dong 
et al. 2014; Long et al. 2008); SCN2A (Lu et al. 1998; 
Schade and Brown 2000), SCN3A (Martin et al. 2007), and 
SCN8A (Drews et al. 2005, 2007). Based on the sequence 
analyses and databases, several transcription factors have 
been proposed to control brain sodium channel expres-
sion (Long et al. 2008). Experimentally, a recent study has 
shown that SCN3A expression is regulated by promoter 
CpG methylation and Methyl-CpG-binding domain pro-
tein 2 (MBD2), (Li et al. 2015). MBD2 targets methylated 
CpG for demethylation, possibly leading to activated tran-
scription. Consistently, knock-down of MBD2 decreased 
SCN3A mRNA levels in a neuroblastoma cell line. In 
seizure-induced mice, MBD2 expression was increased, 
which correlated with decreased CpG methylation, and 
enhanced SCN3A expression (Li et al. 2015).
Another recent development has been the identification 
of receptor for activated C kinase 1 (RACK1) as a repressor 
of SCN1A expression (Dong et al. 2014). The authors iden-
tified a transcriptional silencer in a region between +53 
and +62 bp downstream of SCN1A promotor and used 
EMSA assays to uncover possible transcriptional regula-
tors. RACK1 was found to bind to the silencer in NT2 cells 
(a pluripotent embryonal carcinoma cell line often used for 
differentiation into neurons). Knocking-down RACK1 in 
NT2 cells markedly increased SCN1A mRNA levels (Dong 
et al. 2014).
Sodium channel macromolecular complexes may incor-
porate proteins classically known as voltage-gated sodium 
channel β subunits. These include five different proteins 
termed β1, β1b, β2, β3, and β4. Many groups have studied 
the effect of β subunits on α subunit trafficking and electro-
physiology, mainly from the point of view of protein–pro-
tein interactions (for a recent review, see Namadurai et al. 
2015).
Additionally, sodium channel β subunits have been pro-
posed to regulate α subunits at the transcriptional level. 
One of the first experimental observations was the increase 
in NaV1.1 mRNA and protein levels in the presence of pro-
teases targeting the β2 subunit. The group of Kovacs, and 
others, has demonstrated the sequential mechanism by 
which, first, ADAM10 and BACE1 proteases cleave off the 
extracellular domain of the β2 subunit. Second, γ-secretase 
releases the β2 intracellular domain. And third, the β2 
intracellular domain induces an increase in NaV1.1 mRNA 
and protein levels (Kim et al. 2005, 2007; Wong et al. 
2005), although the precise pathways for β2 internalisation 
into the cell nucleus remain unknown. BACE1-dependent 
sodium channel expression seems to be specific for NaV1.1, 
and mRNA levels of other brain NaV isoforms including 
NaV1.2, NaV1.3 and NaV1.6 are relatively insensitive to 
BACE1 protease activity (Kim et al. 2007, 2011).
Likewise β2, the β1 subunit has been shown to regulate 
NaV expression, and mouse models show changes in brain 
NaV expression and localization upon β1 deletion (Chen 
et al. 2004). In a recent development, β1 subunit silenc-
ing has been shown to result in decreased NaV1.1, NaV1.3 
and NaV1.6 (but not NaV1.2) mRNA and protein levels in 
cells models (Baroni et al. 2014), although the mechanism 
underlying this regulation was not investigated. Although 
β1 subunit is a target for BACE1 in vitro, the question 
remains whether this is physiologically relevant (Wong 
et al. 2005).
Regulation by alternative splicing
The first evidences for alternative splicing of brain sodium 
channels were reported more than 20 years ago (Sarao et al. 
1991; Gustafson et al. 1993), and splicing mechanisms are 
thought to be common to most brain NaV isoforms (Copley 
2004). In particular, SCN1A alternative splicing has been 
extensively studied due to its relevance in CNS disorders 
such as epilepsy (Lossin 2009; Schlachter et al. 2009; Le 
Gal et al. 2011; Thompson et al. 2011).
The best studied SCN1A splicing variants are often 
referred to as the adult and neonatal forms, although both 
forms are expressed in adults. They result from the mutu-
ally exclusive expression of either exon 5A (adult) or 5N 
643An update on transcriptional and post-translational regulation of brain voltage-gated sodium…
1 3
(neonatal). Common SCN1A polymorphisms can have a 
massive effect on the expression of the 5N variant in nor-
mal adults (Tate et al. 2005; Heinzen et al. 2007). The 
5A/5N splicing event can also be modulated by splice-
modifier proteins, including sodium channel modifier 1 
(SCNM1). Very recently, a mutation in SCNM1 has been 
linked to epilepsies possibly via regulation of SCN1A 
splicing leading to reduction of the variant containing exon 
5N (Kasteleijn-Nolst Trenité et al. 2015). SCNM1, as well 
as other splicing regulators such as Rbfox2, can also modu-
late SCN8A splicing (Buchner et al. 2003; Gehman et al. 
2012).
Regulation of brain sodium channels at the 
post‑translational level
From biochemical assays in vitro to targeted purification 
of proteins from tissues, research in sodium channel PTMs 
has recently expanded from (immuno) chemical meth-
ods to embrace mass spectrometry and proteomics. Here, 
we review our current understanding of some of the best 
known sodium channel PTMs. As before, we have included 
NaV1.1, NaV1.2, NaV1.3, and NaV1.6. Where relevant, 
NaV1.5 has also been considered because of the wealth of 
available NaV1.5 PTM data. In particular, NaV1.5 phos-
phorylation, ubiquitylation, and arginine methylation have 
been studied in detail (“Phosphorylation”, “Ubiquitylation” 
and “Arginine methylation”, respectively).
Previously in “Regulation by transcription factors”, we 
have reviewed our knowledge of sodium channel β subunit 
processing by proteases, leading to transcriptional regula-
tion of α subunits. In “Regulation of brain sodium channels 
by proteases”, we have included available data on direct 
proteolysis of α subunits. Although proteolysis is in most 
cases associated with degradation, it can also be regarded 
as PTM if it is limited and specific (Rogers and Overall 
2013).
Phosphorylation
Phosphorylation is the most experimentally observed PTM 
at the proteome-wide level, and it is certainly thought to 
be the most abundant PTM along with N-glycosylation 
(Khoury et al. 2011). Sodium channels are no exception 
to the rule and phosphorylation is the most studied and 
observed sodium channel PTM.
Identified phosphorylation sites
The aim of this subsection is to comprehensively collect 
and update the repertoire of sodium channel ‘phosphorylat-
able’ sites (Table 1). These include phosphosites identified 
by the use of in vitro assays and heterologous expression 
experiments, as well as those identified in sodium chan-
nels isolated from native sources. Data in Table 1 are taken 
from classical papers (Berendt et al. 2010), and previous 
reviews (Cerda et al. 2011; Baek et al. 2011), and updated 
to include recent original articles that described novel phos-
phosites (Marionneau et al. 2012; Baek et al. 2014; Herren 
et al. 2015). Functional consequences of NaV phosphoryla-
tion are discussed below.
Is it safe to assume that if a NaV isoform is phospho-
rylated at a certain residue, then our favourite isoform 
will also be, provided the site is conserved? The general 
answer is No. Visual analysis of phosphosite conservation 
in Table 1 leaves little room for hope, at least according to 
the data currently available. The exception is the interdo-
main linker between domains I and II, which is considered 
the PTM hot-spot (Cantrell and Catterall 2001), and where 
one can find phosphosites conserved among 3, sometimes 
4, of the considered NaV isoforms. Nevertheless, due to the 
substoichiometric and labile nature of phosphorylation, the 
failure to detect a protein modification does not imply that 
a residue is not phosphorylated. Perhaps future comprehen-
sive proteomic studies will demonstrate higher degree in 
phosphosite conservation among NaV isoforms.
Specificity of the functional effect of phosphorylation 
among NaV isoforms
Most of the phosphosites included in Table 1 were identi-
fied by proteomics and mass spectrometry methods, and 
we currently lack information on which protein kinase may 
catalyse phosphorylation of many of the NaV phosphosites. 
Nevertheless, it has long been known that protein kinase C 
(PKC) and cAMP-dependent kinase (PKA) can phospho-
rylate brain NaV channels (West et al. 1991; Numann et al. 
1991; Li et al. 1992, 1993). Other kinases involved in regu-
lating brain NaV phosphorylation are glycogen synthase 
kinase 3 (GSK3) (James et al. 2015), protein kinase CK2 
(Hien et al. 2014), A kinase-anchoring protein 15 (Few 
et al. 2007), Fyn tyrosine kinase (Beacham et al. 2007), 
and p38 mitogen-kinase activated protein kinase (Wittmack 
et al. 2005).
The functional effects of channel phosphorylation on 
NaV electrophysiology often depend on the specific iso-
form of interest. For instance, phosphorylation by PKA and 
PKC results in attenuation of NaV1.2 currents due to defec-
tive channel trafficking to the cell surface (Li et al. 1992). 
But NaV1.6 channels are relatively insensitive to PKA/
PKC regulation (Chen et al. 2008), and NaV1.5 currents 
are enhanced by PKA activation due to increased NaV1.5 
expression at the cell surface (Hallaq et al. 2006). Subtle 
variations in the primary sequence of NaV isoforms must 
underlie such differences. For instance, it is thought that 
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Table 1  Phosphosites of different NaV isoforms
MEQTVLVPPG PDSFNFFTRE SLAAIERRIA EEKAKNPKPD ----KKDDDE    46 NaV1.1 mouse (N terminus)
MARSVLVPPG PDSFRFFTRE SLAAIEQRIA EEKAKRPKQE ---RKDEDDE    47 NaV1.2 rat (N terminus)
MAQALLVPPG PESFRLFTRE SLAAIEKRAA EEKAKKPKKE ----QDNDDE    46 NaV1.3 human (N terminus)
M-ANFLLPRG TSSFRRFTRE SLAAIEKRMA EKQARGSTTL QESREGLPEE    49 NaV1.5 human (N terminus)
MAARVLAPPG PDSFKPFTPE SLANIERRIA ESKLKKPPKA DGSHREDDED    50 NaV1.6 mouse (N terminus)
NGPKPNSDLE AGKNLPFIYG DIPPEMVSEP LEDLDPYYIN KKTFIVLNKG    96 NaV1.1 mouse (N terminus)
NGPKPNSDLE AGKSLPFIYG DIPPEMVSEP LEDLDPYYIN KKTFIVLNKG    97 NaV1.2 rat (N terminus)
NKPKPNSDLE AGKNLPFIYG DIPPEMVSEP LEDLDPYYIN KKTFIVMNKG    96 NaV1.3 human (N terminus)
EAPRPQLDLQ ASKKLPDLYG NPPQELIGEP LEDLDPFYST QKTFIVLNKG    99 NaV1.5 human (N terminus)
SKPKPNSDLE AGKSLPFIYG DIPQGLVAVP LEDFDPYYLT QKTFVVLNRG   100 NaV1.6 mouse (N terminus)
KAIFRFSATS ALYILTPFNP LRKIAIKILV HSLFSMLIMC TILTNCVFMT   146 NaV1.1 mouse (N terminus)
KAISRFSATS ALYILTPFNP IRKLAIKILV HSLFNVLIMC TILTNCVFMT   147 NaV1.2 rat (N terminus)
KAIFRFSATS ALYILTPLNP VRKIAIKILV HSLFSMLIMC TILTNCVFMT   146 NaV1.3 human (N terminus)
KTIFRFSATN ALYVLSPFHP IRRAAVKILV HSLFNMLIMC TILTNCVFMA   149 NaV1.5 human (N terminus)
KTLFRFSATP ALYILSPFNL IRRIAIKILI HSVFSMIIMC TILTNCVFMT   150 NaV1.6 mouse (N terminus)
EFQQMLEQLK KQQEAAQQAA ATTASE---- -HSRE---PS AAGRLSDSSS   484 NaV1.1 mouse (Linker DI-DII)
EFQQMLEQLK KQQEEAQ-AA AAAASA---- -ESRDFSGAG GIGVFSESSS 488 NaV1.2 rat (Linker DI-DII)
EFQQMLEQLK KQQEEAQ--A VAAASA---- -ASRDFSGIG GLGELLESSS   486 NaV1.3 human (Linker DI-DII)
RFQEAMEMLK KEHEALT--- ---------- --------IR GVDTVSRSSL   461 NaV1.5 human (Linker DI-DII)
EFKAMLEQLK KQQEEAQ-AA AMATSAGTVS EDAIEEEGED GVGS-PRSSS   478 NaV1.6 mouse (Linker DI-DII)
EASKLSSKSA KERRNRRKKR KQKEQSGGEE K-DDDEFHKS ESEDSIRRKG   533 NaV1.1 mouse (Linker DI-DII)
VASKLSSKSE KELKNRRKKK KQKEQAGEEE K--EDAVRKS ASEDSIRKKG   536 NaV1.2 rat (Linker DI-DII)
EASKLSSKSA KEWRNRRKKR RQREHLEGNN KGERDSFPKS ESEDSVKRSS   536 NaV1.3 human (Linker DI-DII)
EMSPLAPVNS HERRSKRRKR ----MSSGTE ECGEDRLPKS DSEDGPR--- 504 NaV1.5 human (Linker DI-DII)
ELSKLSSKSA KERRNRRKKR KQKELSEGEE KGDPEKVFKS ESEDGMRRKA   528 NaV1.6 mouse (Linker DI-DII)
FRFSIEGNRL TYEKRYSSPH QSLLSIRGSL FSPRRNSRTS LFSFR--GRA   581 NaV1.1 mouse (Linker DI-DII)
FQFSLEGSRL TYEKRFSSPH QSLLSIRGSL FSPRRNSRAS LFNFK--GRV   584 NaV1.2 rat (Linker DI-DII)
FLFSMDGNRL TSDKKFCSPH QSLLSIRGSL FSPRRNSKTS IFSFR--GRA   584 NaV1.3 human (Linker DI-DII)
---------- ------AMNH LSLTRGLSRT SMKPRSSRGS IFTFR--R-- 534 NaV1.5 human (Linker DI-DII)
FR--LPDNRI G--RKFSIMN QSLLSIPGSP FLSRHNSKSS IFSFRGPGRF   574 NaV1.6 mouse (Linker DI-DII)
KDVGSENDFA DDEHSTFEDN ESRRDSLFVP RRHGERRN-- ---SNLSQTS   626 NaV1.1 mouse (Linker DI-DII)
KDIGSENDFA DDEHSTFEDN DSRRDSLFVP HRHGERRP-- ---SNVSQAS   629 NaV1.2 rat (Linker DI-DII)
KDVGSENDFA DDEHSTFEDS ESRRDSLFVP HRHGERRN-- ---SNVSQAS   629 NaV1.3 human (Linker DI-DII)
RDLGSEADFA DDENSTAGES ESHHTSLLVP --WPLRRT-- ---SAQGQPS 577 NaV1.5 human (Linker DI-DII)
RDPGSENEFA DDEHSTVEES EGRRDSLFIP IRARERRSSY SGYSGYSQCS   624 NaV1.6 mouse (Linker DI-DII)
RSSRMLAVFP ANGKMHSTVD CNGVVSLVG- GPSVPTSPVG QLLPEVIIDK   675 NaV1.1 mouse (Linker DI-DII)
RASRGIPTLP MNGKMHSAVD CNGVVSLVG- GPSALTSPVG QLLPE----- 673 NaV1.2 rat (Linker DI-DII)
MSSRMVPGLP ANGKMHSTVD CNGVVSLVG- GPSALTSPTG QLPPE----- 673 NaV1.3 human (Linker DI-DII)
PGTSA-PGHA LHGKKNSTVD CNGVVSLLGA GDPEATSPGS HLLRPVMLEH   626 NaV1.5 human (Linker DI-DII)
RSSRIFPSLR RSVKRNSTVD CNGVVSLIG- ----PGSHIG RLLPE----- 664 NaV1.6 mouse (Linker DI-DII)
PATDDNGTTT ETEMRKRRSS SFHVSMDFLE DPSQRQRAMS IASILTNTV- 724 NaV1.1 mouse (Linker DI-DII)
------GTTT ETEIRKRRSS SYHVSMDLLE DP-SRQRAMS MASILTNTM- 715 NaV1.2 rat (Linker DI-DII)
------GTTT ETEVRKRRLS SYQISMEMLE DSSGRQRAVS IASILTNTM- 716 NaV1.3 human (Linker DI-DII)
PP--DTTTPS EEPGGPQMLT SQAPCVDGFE EPGARQRALS AVSVLTSAL- 673 NaV1.5 human (Linker DI-DII)
-------ATT EVEIKKKGPG SLLVSMEQLA SYGRKDRINS IMSVVTNTLV   707 NaV1.6 mouse (Linker DI-DII)
EELEESRQKC PPCWYKFSNI FLIWDCSPYW LKVKHIVNLV VMDPFVDLAI   774 NaV1.1 mouse (Linker DI-DII)
EELEESRQKC PPCWYKFANM CLIWDCCKPW LKVKHVVNLV VMDPFVDLAI   765 NaV1.2 rat (Linker DI-DII)
EELEESRQKC PPCWYRFANV FLIWDCCDAW LKVKHLVNLI VMDPFVDLAI   766 NaV1.3 human (Linker DI-DII)
EELEESRHKC PPCWNRLAQR YLIWECCPLW MSIKQGVKLV VMDPFTDLTI   723 NaV1.5 human (Linker DI-DII)
EELEESQRKC PPCWYKFANT FLIWECHPYW IKLKEIVNLI VMDPFVDLAI   757 NaV1.6 mouse (Linker DI-DII)
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NaV1.5 phosphorylation by PKA at S528 masks an endo-
plasmic reticulum retention signal (RRR535), thereby pro-
moting NaV1.5 trafficking to the membrane (Zhou et al. 
2002). This endoplasmic reticulum signal is absent in 
NaV1.2 (RVK585) and modified in NaV1.6 (RFR575).
Opposite functional effects of post-translational modifi-
cations on distinct NaV isoforms have also been observed 
after phosphorylation by Fyn kinase. Fyn kinase phospho-
rylates essential tyrosine residues within the inactivation 
gate of sodium channels, including the equivalent Y1498 
Table 1  continued
YVKRKIYEFI QQSFVKKQKI LDEIKPLDDL NNRKDNCISN HT----TEIG  1070 NaV1.1 mouse (Linker DII-DIII)
FVKRKIREFI QKAFVRKQKA LDEIKPLEDL NNKKDSCISN HTT---IEIG  1062 NaV1.2 rat (Linker DII-DIII)
YVKNKMRECF QKAFFRKPKV IEIHE----- GNKIDSCMSN NTG---IEIS  1058 NaV1.3 human (Linker DII-DIII)
FVKRTTWDFC CGLLRQRPQK PAALAAQGQL ----PSCIAT PYSPPPPETE  1017 NaV1.5 human (Linker DII-DIII)
WAKVKVHAFM QAHF--KQRE ADEVKPLDEL YEKKANCIAN HTG---VDIH  1052 NaV1.6 mouse (Linker DII-DIII)
KDLDCLKDV- --NGTTSGIG TGSSVEKYII DESDYMSFIN NPSLTVTVPI  1117 NaV1.1 mouse (Linker DII-DIII)
KDLNYLKDG- --NGTTSGI- -GSSVEKYVV DESDYMSFIN NPSLTVTVPI  1107 NaV1.2 rat (Linker DII-DIII)
KELNYLRDG- --NGTTSGVG TGSSVEKYVI DENDYMSFIN NPSLTVTVPI  1105 NaV1.3 human (Linker DII-DIII)
KVPPTRKETR FEEGEQPGQG TPGDPE---- ---------- ----PVCVPI  1049 NaV1.5 human (Linker DII-DIII)
RNGDFQKNG- --NGTTSGI- -GSSVEKYII DE-DHMSFIN NPNLTVRVPI  1096 NaV1.6 mouse (Linker DII-DIII)
AVGESDFENL NTEDFSSESD LEESKEKLNE ---------- ---------- 1147 NaV1.1 mouse (Linker DII-DIII)
ALGESDFENL NTEEFSSESD MEESKEKLN- ---------- ---------- 1136 NaV1.2 rat (Linker DII-DIII)
AVGESDFENL NTEEFSSESE LEESKEKLN- ---------- ---------- 1134 NaV1.3 human (Linker DII-DIII)
AVAESDTDDQ EEDEENSLGT EEESSKQQES QPVSGGPEAP PDSRTWSQVS  1099 NaV1.5 human (Linker DII-DIII)
AVGESDFENL NTEDVSSESD PEGSKDKLD- ---------- ---------- 1125 NaV1.6 mouse (Linker DII-DIII)
LYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA  1510 NaV1.1 mouse (Linker DIII-DIV)
LYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA  1500 NaV1.2 rat (Linker DIII-DIV)
LYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA  1495 NaV1.3 human (Linker DIII-DIV)
IYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKLGGQDIFM TEEQKKYYNA  1497 NaV1.5 human (Linker DIII-DIV)
IYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA  1489 NaV1.6 mouse (Linker DIII-DIV)
MKKLGSKKPQ KPIPRPGNKF QGMVFDFVTR QVFDISIMIL ICLNMVTMMV  1560 NaV1.1 mouse (Linker DIII-DIV)
MKKLGSKKPQ KPIPRPANKF QGMVFDFVTK QVFDISIMIL ICLNMVTMMV  1550 NaV1.2 rat (Linker DIII-DIV)
MKKLGSKKPQ KPIPRPANKF QGMVFDFVTR QVFDISIMIL ICLNMVTMMV  1545 NaV1.3 human (Linker DIII-DIV)
MKKLGSKKPQ KPIPRPLNKY QGFIFDIVTK QAFDVTIMFL ICLNMVTMMV  1547 NaV1.5 human (Linker DIII-DIV)
MKKLGSKKPQ KPIPRPLNKI QGIVFDFVTQ QAFDIVIMML ICLNMVTMMV  1539 NaV1.6 mouse (Linker DIII-DIV)
RIHCLDILFA FTKRVLGESG EMDALRIQME ERFMASNPSK VSYQPITTTL  1910 NaV1.1 mouse (C terminus)
RIHCLDILFA FTKRVLGESG EMDALRIQME ERFMASNPSK VSYEPITTTL  1900 NaV1.2 rat (C terminus)
RIHCLDILFA FTKRVLGESG EMDALRIQME DRFMASNPSK VSYEPITTTL  1895 NaV1.3 human (C terminus)
RIHCMDILFA FTKRVLGESG EMDALKIQME EKFMAANPSK ISYEPITTTL  1896 NaV1.5 human (C terminus)
RIHCLDILFA FTKRVLGDSG ELDILRQQME ERFVASNPSK VSYEPITTTL 1888 NaV1.6 mouse (C terminus)
KRKQEEVSAV IIQRAYRRHL LKRTVKQASF TYNKNKL-KG --GANLLVKE  1957 NaV1.1 mouse (C terminus)
KRKQEEVSAI VIQRAYRRYL LKQKVKKVSS IYKKDKG-KE --DEGTPIKE  1947 NaV1.2 rat (C terminus)
KRKQEEVSAA IIQRNFRCYL LKQRLKNISS NYNKEAI-KG --RIDLPIKQ  1942 NaV1.3 human (C terminus)
RRKHEEVSAM VIQRAFRRHL LQRSLKHASF LFRQQAG-SG LSEEDAPERE  1945 NaV1.5 human (C terminus)
RRKQEEVSAV VLQRAYRGHL ARRGF----- ---------- -------ICR  1916 NaV1.6 mouse (C terminus)
DMLIDRI-NE N----SITEK TDLTMSTAAC PPSYDRVTKP IVEKHE---Q  1999 NaV1.1 mouse (C terminus)
DIITDKL-NE N----STPEK TDVTPSTTS- PPSYDSVTKP EKEKFE---K  1988 NaV1.2 rat (C terminus)
DMIIDKL-NG N----STPEK TDGSSSTTS- PPSYDSVTKP DKEKFE---K  1983 NaV1.3 human (C terminus)
GLIAYVM-SE NFSRPLGPPS SSSISSTSF- PPSYDSVTRA TSDNLQVRGS  1993 NaV1.5 human (C terminus)
KITSNKLENG G----THREK KESTPSTAS- LPSYDSVTKP DKEKQQRAEE  1961 NaV1.6 mouse (C terminus)
EGKDEKAKGK ---------- --- 2009 NaV1.1 mouse (C terminus)
DKSEKEDKGK ------DIRE SKK                               2005 NaV1.2 rat (C terminus)
DKPEKESKGK ------EVRE NQK                               2000 NaV1.3 human (C terminus)
DYSHSEDLAD FPPSPDRDRE SIV                               2016 NaV1.5 human (C terminus)
GRRERAKRQK ------EVRE SKC                               1978 NaV1.6 mouse (C terminus)
Phosphorylated residues are shown bold and shadowed
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(NaV1.2) and Y1495 (NaV1.5). Yet, the functional effect 
of phosphorylation by Fyn on channel inactivation is a 
negative (NaV1.2) or positive (NaV1.5) shift in the voltage 
dependence of inactivation (Beacham et al. 2007; Ahern 
et al. 2005). The simplest explanation is that Fyn phos-
phorylates other Tyr residues within NaV1.2 and NaV1.5 
sequences, and this has indeed been demonstrated for 
NaV1.2 (including Y66, Y1497, and Y1893), (Beacham 
et al. 2007). Nevertheless, recent work has reported that 
distinct splicing variants of the same NaV isoform show 
different electrophysiological behaviour upon phosphoryla-
tion by Fyn, which introduces another level of complexity 
(Iqbal et al. 2015).
Ubiquitylation
Protein ubiquitylation (or ubiquitination) is a post-trans-
lational modification that involves the orchestrated func-
tion of three types of enzymes. First, ubiquitin activating 
enzyme (E1) catalyses thioester formation between the C 
terminus of ubiquitin and an internal cysteine. Second, acti-
vated ubiquitin is transferred to the ubiquitin conjugating 
enzyme (E2). Third, ubiquitylation of the substrate protein 
is catalysed by ubiquitin ligases (E3), which covalently 
attach ubiquitin molecules to lysine residues within the tar-
get sequence. Ubiquitylation is often associated with pro-
tein degradation.
There are hundreds of E3 ubiquitin ligases, usually clas-
sified into two groups: HECT (homologous to E6-AP C 
terminus) ligases, and RING (really interesting new gene) 
ligases (Goel et al. 2015). Until 2015, it was thought that 
only HECT ligases could catalyse sodium channel ubiqui-
tylation (see below).
The most studied molecular mechanism for sodium 
channel ubiquitylation involves channel recognition by 
Nedd4-2 ubiquitin ligases (HECT-type ligases) via protein–
protein interaction between the WW4 domain of Nedd4-2, 
and the PY motif of neuronal and cardiac sodium channels 
(Fotia et al. 2004; van Bemmelen et al. 2004). Ubiquityla-
tion by Nedd4-2 has been shown to tag sodium channels 
for internalisation from the cell surface, including NaV1.2 
(Fotia et al. 2004), NaV1.6 (Gasser et al. 2010), and NaV1.5 
(Rougier et al. 2005). However, in most cases, the precise 
modification site(s), i.e., the Lys residues that are ubiquity-
lated, remain to be confirmed.
Very recently, compelling evidence has been presented 
that shows ubiquitylation of sodium channels in zebra fish 
CNS by RNF121, a member of the RING family of E3 
ubiquitin ligases (Ogino et al. 2015). From the initial obser-
vation that zebra fish bearing mutations in RNF121 present 
defective NaV trafficking in neurons and skeletal muscle, 
the investigators moved on to perform heterologous expres-
sion of NaV1.6 and RNF121 in HEK 293T cells. Results 
showed increased NaV1.6 degradation upon co-expression 
of RNF121 but, intriguingly, enhanced NaV1.6 membrane 
localization when co-expressed with RNF121 and auxiliary 
NaV β subunits (Ogino et al. 2015).
Arginine methylation
Arginine methylation consists on the addition of methyl 
groups to arginine residues of proteins. Arginine methyla-
tion is catalysed by protein arginine methyl transferases 
(PRMTs) that transfer a methyl group from S-adenosyl-
l-methionine (SAM) to the target arginine. Arginine meth-
ylation has recently been reported as a novel post-transla-
tional modification of the voltage-gated sodium channel 
family using NaV1.5 as a model system (Beltran-Alvarez 
et al. 2011).
The groups of Comb and Trimmer have described argi-
nine methylation of brain sodium channels. Using a prot-
eomic approach and bespoke antibodies that recognise 
peptides bearing methylated arginine, the group of Comb 
reported arginine methylation of NaV1.1, NaV1.2 and 
NaV1.5 in the mouse brain (Guo et al. 2014). In parallel, 
the group of Trimmer described arginine methylation of 
NaV1.2 purified from rat brain (Baek et al. 2014). We ana-
lysed the methylation sites reported by the three referenced 
articles (Beltran-Alvarez et al. 2011; Guo et al. 2014; Baek 
et al. 2014), and found that three sites have been observed 
by at least two independent studies (Table 2).
The functional consequences of sodium channel modi-
fication by arginine methylation have been documented. 
Available electrophysiological data are consistent with 
an increase in sodium current density, most likely due to 
enhanced NaV membrane expression (Beltran-Alvarez et al. 
2013; Baek et al. 2014). Additionally, the group of Trimmer 
reported considerable acceleration in NaV1.2 recovery from 
inactivation when arginine methylation was enhanced (Baek 
et al. 2014). Remarkably, arginine methylation is an example 
of PTM conservation among NaV isoforms, even if catalysed 
by different enzymes: NaV1.2 is methylated by PRMT8 
(mostly expressed in the CNS), while NaV1.5 methylation is 
catalysed by PRMT3 and -5 (ubiquitously expressed).
Other known post‑translational modifications
We would like to mention that sodium channels have long 
been known to undergo cysteine modifications including 
S-palmitoylation (Schmidt and Catterall 1987; Bosmans 
et al. 2011), and S-nitrosylation (Renganathan et al. 2002). 
Methionine oxidation of sodium channels has previously 
been reviewed (Cui et al. 2012). SUMOylation of the 
NaV1.7 isoform has been described, but available data sug-
gest that SUMOylation may not be conserved in CNS NaV 
isoforms (Dustrude et al. 2013).
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Another well-known PTM, N-glycosylation, has been 
mostly studied in the cardiac isoform of the sodium chan-
nel, and several excellent reviews have recently been pub-
lished (Baycin-Hizal et al. 2014; Marionneau and Abriel 
2015). Perhaps the latest studies are those from the Chat-
elier and the Decosterd–Abriel groups, which have pro-
posed alternative trafficking pathways for differentially gly-
cosylated NaV, using NaV1.5 and NaV1.7 as study models 
(Mercier et al. 2015; Laedermann et al. 2013, respectively).
Other possible post‑translational modifications?
The advent of large-scale proteomics including the pub-
lication of human proteome maps is revolutionising life 
sciences. The ion channel field can also benefit from the 
analysis of big data to anticipate and identify challenges 
and opportunities, particularly in the field of PTMs. With 
this in mind, we searched Phosphositeplus (Hornbeck et al. 
2015) for PTMs of NaV isoforms. The database contains 
potentially novel sodium channel modifications includ-
ing Lys acetylation, which is reported for NaV1.1, NaV1.2, 
NaV1.3, NaV1.5 and NaV1.6, and Lys methylation, which is 
included for NaV1.2 and NaV1.6.
Although promising at first sight, available data must be 
regarded with care. Conservation of the reported post-trans-
lationally acetylated or methylated Lys site among NaV 
isoforms was very low. The finding worth mentioning was 
interspecies conservation of NaV1.1 acetylation at K1948 
in human and mouse samples. Although K1948 acetylation 
was observed in unrelated experiments, it must be noted 
that the source of tissue was not brain but colon cancer.
Cross‑talk between sodium channel PTMs
Cross-talk, or interplay, between PTMs includes the regu-
latory mechanisms by which PTMs work together to 
determine protein function. Cross-talk between sodium 
channel phosphorylation, and arginine methylation, has 
been reported. The group of Trimmer reported cross-talk 
between NaV1.2 arginine methylation and phosphoryla-
tion (Baek et al. 2014). In this study, the authors studied 
NaV1.2 PTMs in the rat brain. NaV1.2 was immunopurified, 
digested and subjected to mass spectrometry analysis. An 
initial observation was that detected NaV1.2 peptides har-
boured either arginine methylation or phosphorylation, but 
not both PTMs on the same peptide. Convincingly, these 
two PTMs were reciprocally regulated in response to acute 
seizure: e.g., R563 methylation (see also Table 2) increased 
but S554 and S568 phosphorylation decreased after induc-
tion of seizure in rats (Baek et al. 2014). The most likely 
mechanism for this interplay between sodium channel argi-
nine methylation and phosphorylation is the modification 
of kinetic specificity constants of serine phosphorylation Ta
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upon methylation of a neighbouring arginine, and viceversa 
(Beltran-Alvarez et al. 2015). Nevertheless, the functional 
consequences of phosphorylation—arginine methylation 
cross-talk remain to be elucidated.
Additionally, cross-regulation between NaV1.6 phos-
phorylation, and ubiquitylation, has been observed. On 
the one hand, NaV1.6 is phosphorylated by p38 MAPK at 
position S553. On the other, NaV1.6 is ubiquitylated by 
Nedd4-2 after recognition of the PY motif (Pro-Ser-Tyr) at 
the C terminus of the channel. Results from the group of 
Dib-Hajj suggested that S553 phosphorylation enables fur-
ther NaV1.6 ubiquitylation and internalisation of the chan-
nel (Gasser et al. 2010). A similar mechanism has recently 
been proposed for NaV1.2 whereby phosphorylation of 
T1966 by GSK3 primes recognition by Nedd4-2 via the 
NaV1.2 PY motif (PPSY1975), (James et al. 2015).
Regulation of brain sodium channels by proteases
Voltage-gated sodium channel density has long been known 
to be regulated by proteases under normal (Paillart et al. 
1996) and stress conditions (Iwata et al. 2004). Among 
the most important proteases in mammalian cells stand the 
calpains, which target hundreds of proteins (Grimm et al. 
2012). The group of Meany has revealed the bases of cal-
pain-dependent proteolysis of NaV1.2.
Using rat brain homogenates, they showed that calpain 
cleaves NaV1.2 (but not NaV1.1) at two sites, i.e., the inter-
domain linkers between domains I and II, and between 
domains II and III (von Reyn et al. 2009). Intriguingly, 
most of the calpain sodium channel fragment products 
localise at the plasma membrane 6 h after calpain activa-
tion, and possibly interact (von Reyn et al. 2009). Per-
haps the simplest explanation is that distinct sodium frag-
ments still retain the protein–protein interactions that hold 
the sodium channel macromolecular complex together, 
and thus control the break-down of the complex. A more 
thought-provoking alternative is that sodium channel post-
translational proteolysis creates new proteins with modified 
biological activities.
The group of Meany has dissected the mechanisms of 
NaV1.2 proteolysis in cellular and mouse models of neu-
ronal injury (von Reyn et al. 2012; Schoch et al. 2013), 
opening opportunities for treatment and therapy of trau-
matic brain injury. In this line, other researchers have 
recently described the beneficial effect of calpain inhibitors 
on brain sodium channel expression and electrophysiology 
in a model of diabetic neuropathy (Kharatmal et al. 2015).
The other example of sodium channel processing by 
proteases is the excision of the initiation methionine by 
aminopeptidases. This has been shown for NaV1.5 (fol-
lowed by N-terminal acetylation of the resulting initiation 
alanine) in cardiac disease (Beltran-Alvarez et al. 2014). 
Whether NaV1.5 or other NaV isoforms are devoid of Met 
residues (or post-translationally acetylated) in normal tis-
sue is unknown.
Conclusions and perspective
Research in the voltage-gated sodium channel field has 
grown linearly for the last 20 years. While the interest in 
transcriptional mechanisms regulating sodium channel 
expression has also grown steadily, we have observed an 
exponential trend in the number of publications related to 
sodium channel post-translational regulation. We predict 
that this growth will keep pace over the coming years. The 
aim of this review was to provide the current state of the 
art of the transcriptional and post-translational regulation 
of sodium channels, and thus set the ground for further 
research opportunities and discoveries.
Our understanding of transcriptional mechanisms gov-
erning brain sodium channel expression is far from compre-
hensive, and the ongoing research efforts of the ENCODE 
Consortium will surely encourage groups around the globe 
to dissect the molecular mechanism controlling NaV tran-
scription. Analogously, there are new questions in the field 
of PTM of sodium channels, in particular related to cross-
talk among co-occurring types of PTM. As an example, the 
functional consequences of the interplay between phospho-
rylation and arginine methylation are intriguing, because 
the latter is thought to be a rather stable PTM (Bedford and 
Clarke 2009). The dynamic sequence of PTM events, thus, 
acquires vital relevance. Our incomplete understanding of 
proteolysis and degradation pathways of sodium channels 
also warrants further research in the area.
From the point of view of cell biology, biochemistry and 
electrophysiology, we predict that major advances in our 
understanding of NaV regulation will be made in two main 
directions. First, systems biology approaches will inte-
grate knowledge on NaV biology, including transcriptional 
and post-translational regulation. This may be done using 
mathematical models and simulations of protein expres-
sion, function and degradation at the single molecule level, 
or, e.g., at the level of action potentials. Second, structural 
insights into whole sodium channel proteins, or isolated 
domains, will provide the framework to rationalise possible 
interactions between PTMs.
Additionally, research on NaV is intrinsically associated 
to biomedical sciences, given the prominent relevance of 
these channels in a range of neurological and cardiac dis-
orders. In this respect, in the following years we expect 
reports on quantitative experiments identifying changes in 
PTM patterns in disease (some recent examples include 
Baek et al. 2014; and Herren et al. 2015). The effect of 
sodium channel proteolysis in major neurological diseases 
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is also an emerging field of research (Corbett et al. 2013), 
which includes the identification of genetic mutations 
in proteases affecting sodium channel levels (Kim et al. 
2014).
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